[
Antengene licenses ATG-106 to K2 Therapeutics for $20M upfront
[og_img]
https://www.investing.com/news/company-news/antengene-licenses-atg106-to-k2-therapeutics-for-20m-upfront-93CH-4751700
Investing.com
Antengene licenses ATG-106 to K2 Therapeutics for $20M upfront
Related articles




